Óscar Soto-Angona

ORCID: 0000-0003-0234-4280
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Treatment of Major Depression
  • Tryptophan and brain disorders
  • Chemical synthesis and alkaloids
  • Hematological disorders and diagnostics
  • Myasthenia Gravis and Thymoma
  • Psychedelics and Drug Studies
  • Neurological Complications and Syndromes
  • Electroconvulsive Therapy Studies
  • Pericarditis and Cardiac Tamponade
  • Personality Disorders and Psychopathology
  • Infectious Diseases and Tuberculosis
  • Spondyloarthritis Studies and Treatments
  • Endoplasmic Reticulum Stress and Disease
  • Functional Brain Connectivity Studies
  • Zebrafish Biomedical Research Applications
  • Glioma Diagnosis and Treatment
  • Pharmaceutical and Antibiotic Environmental Impacts
  • Healthcare Decision-Making and Restraints
  • Muscle and Compartmental Disorders
  • Autoimmune and Inflammatory Disorders
  • Advanced MRI Techniques and Applications
  • Neurotransmitter Receptor Influence on Behavior
  • Hepatitis C virus research
  • Oral Health Pathology and Treatment
  • Blood groups and transfusion

Institut de Recerca Sant Joan de Déu
2024-2025

Universitat Autònoma de Barcelona
2023-2025

Parc Sanitari Sant Joan de Déu
2024-2025

Vall d'Hebron Hospital Universitari
2020-2023

Vall d'Hebron Institut de Recerca
2023

Universitat Ramon Llull
2022

Universidad de Valladolid
2017

Florida College
1996

University of South Florida
1996

Hospital Clínico San Carlos
1994

Psychotherapy for Prolonged Grief Disorder (PGD), a condition characterized by an intense and persistent grief response, has received increased attention over the past decades. Evidence-based approaches to prevent PGD are currently scarce, not always effective. This paper introduces protocol clinical trial exploring effectiveness of Meaning Reconstruction psychotherapy approach (MR) assisted with ayahuasca, traditional indigenous medicine. The outlined is three-arm, non-randomized controlled...

10.3389/fpsyt.2024.1484736 article EN cc-by Frontiers in Psychiatry 2025-01-07

The number of people suffering from mental health problems is rising, with anxiety and depression now the most commonly diagnosed psychiatric conditions. Selective serotonin reuptake inhibitors (SSRIs) are one prescribed pharmaceuticals to treat these conditions, which has led their common detection in many aquatic ecosystems. As monoaminergic system shows a high degree structural conservation across diverse animal phyla, reasonable assumption that environmental levels SSRIs surface water...

10.3389/fphys.2022.1040598 article EN cc-by Frontiers in Physiology 2022-11-18

Functional neurological disorder (FND) is a complex neuropsychiatric condition characterized by the presence of symptoms and signs (either motor or sensory) that cannot be explained any known medical mental disease. It frequently presented with psychiatric comorbidities, such as major depression. Its prognosis poor, low improvement recovery rates at 1 year after their onset, no particular treatment has demonstrated significant efficacy in this regard. Here, we describe management patient...

10.1177/20451253211022187 article EN cc-by-nc Therapeutic Advances in Psychopharmacology 2021-01-01

Severe neurologic complications following treatment with cyclosporine are uncommon. They tend to occur during the first month of and disappear after withdrawal or reduction dose drug. We report case a man who underwent liver transplantation subsequently developed severe central nervous system toxicity. After two years receiving cyclosporine, he presented brachial monoparesis complex visual disturbance. Symptoms slowly worsened four months. On admission, had confusion seizures. Multiple areas...

10.1097/00002826-199406000-00010 article EN Clinical Neuropharmacology 1994-06-01

Júlia Vendrell-Serres, Óscar Soto-Angona, Amanda Rodríguez-Urrutia, Benedetta Inzoli, Antonia López González, Josep Antoni Ramos-Quiroga. Clin Psychopharmacol Neurosci -0001;0:. https://doi.org/10.9758/cpn.23.1097

10.9758/cpn.23.1097 article IT Clinical Psychopharmacology and Neuroscience 2023-09-06

Marc Ferrer, Óscar Soto-Angona, María Soler-Artigas, Pol Ibáñez, Christian Fadeuilhe, Raúl Felipe Palma-Álvarez, Raquefet Lidai, Sebastian Vargas-Cáceres, Ángeles Torrecilla, Anna López, Josep Antoni Ramos-Quiroga. Clin Psychopharmacol Neurosci 2022;20:482-90. https://doi.org/10.9758/cpn.2022.20.3.482

10.9758/cpn.2022.20.3.482 article ES Clinical Psychopharmacology and Neuroscience 2022-07-26

Presentation of CaseA 37-year-old man was admitted to the hospital because collapse.The patient unmarried and unemployed a former smoker. He had abused alcohol since age 13 years been for detoxification on numerous occasions abuse use illicit drugs. Since his early teens, he an eating disorder that led obesity. During 10 before admission, asthma, proteinuria, hypertension. Six began intermittent doses colchicine indomethacin gouty arthritis.Three .

10.1056/nejmcpc030008 article EN New England Journal of Medicine 2003-10-22
Coming Soon ...